Search research articles
Contact Us
Filters
Showing results (151-160 of 181) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
Michael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
Michael J Morris, Neeta Pandit-Taskar, Jorge Carrasquillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 4, 2025
Summary of the 2024 Update of the North American Guidelines for Pediatric Administered Radiopharmaceutical Activities
S Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Journal of Nuclear Medicine Technology
|
July 15, 2025
2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities
S Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Pediatric Blood & Cancer
|
September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 2019
<sup>89</sup>Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W S Jauw, Joseph A O'Donoghue, Josée M Zijlstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 21, 2024
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer
Samuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.
Clinical Nuclear Medicine
|
January 9, 2025
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients
Jeremy McGale, Sakshi Khurana, Harrison Howell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2016
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
Neeta Pandit-Taskar, Joseph A O'Donoghue, Shutian Ruan, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 181) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
Michael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
Michael J Morris, Neeta Pandit-Taskar, Jorge Carrasquillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 4, 2025
Summary of the 2024 Update of the North American Guidelines for Pediatric Administered Radiopharmaceutical Activities
S Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Journal of Nuclear Medicine Technology
|
July 15, 2025
2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities
S Ted Treves, Frederic H Fahey, Valentina Ferrer Valencia, et al.
Pediatric Blood & Cancer
|
September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 2019
<sup>89</sup>Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W S Jauw, Joseph A O'Donoghue, Josée M Zijlstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 21, 2024
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer
Samuel L Cytryn, Neeta Pandit-Taskar, Melissa A Lumish, et al.
Clinical Nuclear Medicine
|
January 9, 2025
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients
Jeremy McGale, Sakshi Khurana, Harrison Howell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2016
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
Neeta Pandit-Taskar, Joseph A O'Donoghue, Shutian Ruan, et al.
Page
of 19